APRIL SUMMERFIELD: Open Payments
NPI 1770628679 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 32 payments from 10 companies in 2025. Trend: 2023 $757 · 2024 $855 · 2025 $708
Food & beverage: $609Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $253 |
| Biogen, Inc. | 6 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $64 |
| SHIELD THERAPEUTICS INC | 4 | $64 |
| PFIZER INC. | 3 | $52 |
| ABBVIE INC. | 1 | $31 |
| Organon LLC | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Veozah, ZURZUVAE, ACCRUFER, ABRYSVO, Lynkuet, Mirena, LILETTA, NEXPLANON.
Industry payments across NY — which companies pay providers there.
